Retatrutide (GLP-3) Research Peptide
Price Comparison
Compare retatrutide (GLP-3) research peptide prices across verified vendors. Find the lowest price per mg on this triple receptor agonist research compound.
← View All Peptides
What is Retatrutide (GLP-3)? Retatrutide (referred to on this site as GLP-3) is a triple GLP-1/GIP/Glucagon receptor agonist research compound. It simultaneously targets three distinct receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). This triple agonism mechanism is the subject of significant metabolic research interest. Retatrutide is currently in Phase 3 clinical trials as a pharmaceutical candidate. As a research compound it is sold strictly for in vitro laboratory use and is not approved by the FDA for human consumption.
⚠ For laboratory research use only. Not for human consumption. This site does not sell, manufacture, or ship any compounds.
⚠ For laboratory research use only. Not for human consumption. This site does not sell, manufacture, or ship any compounds.
Compare
Retatrutide (GLP-3) Price Comparison
🏷️ Exclusive Discount Codes
Click to copy — use at checkout
Atomiklabz.com
15% OFF entire order
✅ Copied!
ZestyRatResearch.com
10% OFF entire order
✅ Copied!
Midwest Peptide
10% OFF entire order
✅ Copied!
| Compound | Vendor | Size | Price | Price / mg | Coupon Code | Purchase Link | |
|---|---|---|---|---|---|---|---|
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Apollo Peptide Sciences | 10 mg | $136 | $13.60/mg | — | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Apollo Peptide Sciences | 30 mg | $211 | $7.03/mg | — | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Apollo Peptide Sciences | 60 mg | $310 | $5.17/mg | — | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Purple Peptides | 10 mg | $129 | $12.90/mg | — | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Purple Peptides | 30 mg | $219 | $7.30/mg | — | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Midwest Peptide | 10 mg | $59 | $5.90/mg | RIPPED10 10% OFF | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Atomiklabz.com | 10 mg | $54.50 | $5.45/mg | BOGO Deal Dpsave15 15% OFF | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | ZestyRatResearch.com | 10 mg | $89.99 | $9.00/mg | brutal 10% OFF | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | Atomiklabz.com | 24 mg | $104.50 | $4.35/mg Best $/mg | BOGO Deal Dpsave15 15% OFF | View Deal |
|
GLP-3 (R) GLP-3
Retatrutide analog — triple receptor
|
⬡ Metabolic Research Compounds | ZestyRatResearch.com | 30 mg | $249.99 | $8.33/mg | brutal 10% OFF | View Deal |
Atomiklabz.com · 10 mg
$54.50
$5.45/mg
View Deal ↗
ⓘ Prices subject to change. Always verify on vendor site before purchasing. Full disclosure ↓
FAQ
Frequently Asked Questions
Retatrutide is a triple GLP-1/GIP/Glucagon receptor agonist research compound. It targets three receptors simultaneously and is currently in Phase 3 pharmaceutical trials. As a research compound it is sold strictly for in vitro laboratory use only and is not FDA approved.
Based on current vendor pricing, the lowest price per mg for retatrutide research compound is $4.35/mg from Atomiklabz.com on their 24mg vial with BOGO pricing. Use code Dpsave15 for an additional 15% off.
Tirzepatide is a dual GLP-1/GIP receptor agonist while retatrutide adds a third mechanism by also targeting the glucagon receptor (GCGR). Both are research compounds sold strictly for laboratory use and are not equivalent to any FDA-approved prescription drugs.
On PeptidePriceFinder.com, GLP-3 (R) refers to the triple GLP-1/GIP/Glucagon receptor agonist research compound class that includes retatrutide analogs. This naming describes the receptor mechanism, not a generic drug name, and these compounds are not equivalent to any FDA-approved prescription medication.